Daily BriefsHealthcare

Daily Brief Health Care: InMode Ltd and more

In today’s briefing:

  • InMode Ltd (INMD US): Decelerating Growth & Unfavorable Macro Environment Are Major Concerns

InMode Ltd (INMD US): Decelerating Growth & Unfavorable Macro Environment Are Major Concerns

By Tina Banerjee

  • InMode Ltd (INMD US) reported record-high quarterly revenue of $134M in Q4, up 21% YoY, mainly driven by the strong demand for its innovative, energy-based, minimally invasive product platforms. 
  • However, quarterly revenue growth is deteriorating since Q3 2021. Q4 2022 revenue growth of 21% is the lowest in last two years or eight quarters.
  • Demand for aesthetic procedures in the U.S., which is the core market for InMode is expected to deteriorate in next 6–12 months due to macroeconomic headwind.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars